Report Type
Single Stock Research Reports
Recent single stock reports highlight a recurring theme of solid top-line performance paired with aggressive strategic reinvestment, though varied operational headwinds are impacting near-term profitability across sectors. Veralto and Fluence Energy reported revenue largely in line with expectations, yet experienced contrasting margin outcomes; Veralto achieved a 24.6% operating margin beat, while Fluence's gross margins were compressed to 5.6% due to project-specific cost overruns. In the technology space, Alphabet’s massive AI build-out is reflected in 2026 Capex guidance of $175-185 billion, a shift that is forcing analysts to abandon free cash flow yield in favor of P/E and EBITDA valuation frameworks. Growth outlooks remain cautious, with Match Group signaling softer 2026 revenue due to regulatory costs and Veralto projecting moderate sales growth between LSD+ and MSD+. Macroeconomic risks are also tempering sentiment, as evidenced by downgrades for Harbour Energy driven by anticipated 2026 LNG oversupply and high leverage. Collectively, these reports underscore a market environment where robust demand and backlogs, such as Fluence’s $5.5 billion, must be weighed against rising capital intensity and shifting valuation metrics.
527 reports available
All reports
Page 12 of 22
NEC CEO/CFO Meeting: Improving IT Services Productivity Through AI Tools
Goldman Sachs · May 18, 2026
Senior Housing Transition Underway
Goldman Sachs · May 18, 2026
Tencent Holdings: Pivoting for Long-Term Success
Goldman Sachs · May 18, 2026
York Space Systems (YSS): Incremental Uncertainty in the Revenue Growth Trajectory
Goldman Sachs · May 18, 2026
Sunrise Changes to Estimates and Target Price
Goldman Sachs · May 18, 2026
Silergy Corp Data Center and Auto Segments Set to Fuel Next Earnings Upcycle
Goldman Sachs · May 18, 2026
Sonova Holdings FY26 Results Supported by Strong Momentum on Hearing Aids Wholesale Business
Goldman Sachs · May 18, 2026
Regeneron Pharmaceuticals Inc. (REGN): Ph3 Anti-LAG-3 Study In First-Line Metastatic Melanoma Fails
Goldman Sachs · May 18, 2026
Tata Steel Q4FY26 Results Review
Goldman Sachs · May 18, 2026
CFO Transition Formalised
Goldman Sachs · May 18, 2026
Power Semiconductors and Silicon Photonics with Node Migration at China Semis Panel
Goldman Sachs · May 18, 2026
Brambles First Take Trading Update
Goldman Sachs · May 18, 2026
Solid Quarter and Incremental eIPP Investment
Goldman Sachs · May 18, 2026
ADNOC Distribution: Strong 1Q Execution Despite Mobility Disruption
Goldman Sachs · May 14, 2026
Samsung F&M 1Q26 Review
Goldman Sachs · May 14, 2026
nCino nSight 2026 Agentic Operating System and Bank AI Priorities
Goldman Sachs · May 14, 2026
Cisco Systems Inc F3Q26 Review
Goldman Sachs · May 14, 2026
Updating Estimates to Reflect Industry Outlook
Goldman Sachs · May 14, 2026
Focus on Near-Term Headwinds and FCF Generation Driving Capital Returns
Goldman Sachs · May 14, 2026
Versant Media Group 1Q26 First Take
Goldman Sachs · May 14, 2026
Yamato Holdings Booking of Extraordinary Loss on Subsidiary Transfer
Goldman Sachs Japan Co., Ltd. · May 14, 2026
Key Takeaways From Investor Event Digital Science In Focus
Goldman Sachs · May 14, 2026
Nifco Inc. First Take: Results and Guidance Below Expectations
Goldman Sachs · May 14, 2026
Trend Micro Profits Miss Consensus but in Line with Guidance
Goldman Sachs · May 14, 2026